IB

Active Director Director DIN 10808817
DIN 10808817 First appointment Oct 2024 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2024
Shareholding value •••• Premium profile

About Indu Bala

Data last updated:

Indu Bala is a Director at Philanthropy Pharmaceuticals Private Limited (since 2024). The company operates in Trading. Philanthropy Pharmaceuticals Private Limited reported revenue of ₹5,652 (FY 2024).

DIN 10808817
Primary Designation Director
Industry Trading
First Appointment 15 Oct 2024
Oldest Company Age 5 yrs
Largest company Philanthropy Pharmaceuticals Private Limited · ₹5,652 (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Oct 20242021₹5,652 (FY 2024)Active

Board colleagues of Indu Bala

Directorship timeline

Open interactive timeline →
Philanthropy Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Indu Bala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Indu Bala

Indu Bala currently holds 1 directorship: Philanthropy Pharmaceuticals Private Limited (Director, since 15 Oct 2024, revenue ₹5,652 (FY 2024)).

Indu Bala was first appointed on 15 Oct 2024 as Director at Philanthropy Pharmaceuticals Private Limited.

The current boards of Indu Bala's companies include Anshul Sharma (Philanthropy Pharmaceuticals Private Limited), Manish Gangwar (Philanthropy Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available